COMPARATIVE EFFECTIVENESS OF GRANULOCYTE COLONY-STIMULATING FACTORS (G-CSF) FOR REDUCING INCIDENCE OF FEBRILE NEUTROPENIA (FN) -RELATED HOSPITALIZATION: A RETROSPECTIVE COHORT STUDY USING GERMAN CLAIMS DATA

被引：3
|
作者：
Wetten, S. [1 ]
Li, X. [2 ]
Haas, J. [3 ]
Worth, G. [4 ]
Jacob, C. [3 ]
Braun, S. [3 ]
Tzivelekis, S. [2 ]
机构：
[1] Amgen Ltd, Uxbridge, Middx, England
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
[3] Xcenda GmbH, Hannover, Germany
[4] Amgen Ltd, Zug, Switzerland
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.1042
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN27
引用
收藏
页码：A434 / A434
页数：1
相关论文
共 45 条
  • [1] Comparative effectiveness of colony-stimulating factors for febrile neutropenia: a retrospective study
    Tan, Hiangkiat
    Tomic, Karen
    Hurley, Dana
    Daniel, Gregory
    Barron, Rich
    Malin, Jen
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (01) : 79 - 86
  • [2] Appropriateness of using granulocyte colony-stimulating factor (G-CSF) for primary prophylaxis of febrile neutropenia in solid tumors
    Laali, Elahe
    Fazli, Jinous
    Sadighi, Sanambar
    Mohammadi, Mehdi
    Gholami, Kheirollah
    Jahangard-Rafsanjani, Zahra
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (02) : 428 - 433
  • [3] COST-EFFECTIVENESS OF GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF) AS ADJUNCTIVE THERAPY IN CANCER PATIENTS WITH ESTABLISHED FEBRILE NEUTROPENIA
    Tong, W. X.
    Wang, X. J.
    Chan, A.
    VALUE IN HEALTH, 2016, 19 (07) : A912 - A912
  • [4] Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer
    Matti S. Aapro
    Stephen Chaplin
    Paul Cornes
    Sebastian Howe
    Hartmut Link
    Natalia Koptelova
    Andrea Mehl
    Mario Di Palma
    Bridgette Kanz Schroader
    Robert Terkola
    Supportive Care in Cancer, 2023, 31
  • [5] Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer
    Aapro, Matti S.
    Chaplin, Stephen
    Cornes, Paul
    Howe, Sebastian
    Link, Hartmut
    Koptelova, Natalia
    Mehl, Andrea
    Di Palma, Mario
    Schroader, Bridgette Kanz
    Terkola, Robert
    SUPPORTIVE CARE IN CANCER, 2023, 31 (10)
  • [6] Febrile neutropenia primary prophylaxis with granulocyte-colony stimulating factors (G-CSF) in breast cancer
    Younis, T.
    Rayson, D.
    Skedgel, C.
    CANCER RESEARCH, 2013, 73
  • [7] Retrospective Comparison of Neutropenia in Children With Ewing Sarcoma Treated With Chemotherapy and Granulocyte Colony-Stimulating Factor (G-CSF) or Pegylated G-CSF
    Milano-Bausset, Emilie
    Gaudart, Jean
    Rome, Angelique
    Coze, Carole
    Gentet, Jean Claude
    Padovani, Laetitia
    Lacarelle, Bruno
    Andre, Nicolas
    CLINICAL THERAPEUTICS, 2009, 31 : 2388 - 2395
  • [8] Evaluating the appropriateness of granulocyte colony-stimulating factor (G-CSF) use in patients (pts) receiving myelosuppressive chemotherapy by febrile neutropenia (FN) risk level.
    Baig, Hassam
    Klippel, Zandra Karina
    Pirolli, Melissa A.
    Somlo, Barbara
    Eisen, Melissa
    Stryker, Scott
    Tzivelekis, Spiros
    Morrow, Phuong Khanh H.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [9] Endogenous granulocyte colony-stimulating factor (G-CSF) levels in chemotherapy-induced neutropenia and in ;neutropenia related with primary diseases
    Kavgaci, H
    Ozdemir, F
    Aydin, F
    Yavuz, A
    Yavuz, M
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2002, 21 (04) : 475 - 479
  • [10] Febrile neutropenia (FN) risk assessment and granulocyte colony-stimulating factor (G-CSF) guideline adherence in patients with solid tumours or lymphoma - results from a German prospective multicentre observational study (PROTECT)
    Kurbacher, C.
    Eschenburg, H.
    Steffens, C. -C.
    Schmidt, M.
    Otremba, B.
    Huebel, K.
    Eustermann, H.
    Friebel, A.
    Goehler, T.
    ONKOLOGIE, 2012, 35 : 73 - 73
12345